US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 8.790
  • +0.120+1.38%
Close Jul 25 16:00 ET
  • 8.940
  • +0.150+1.71%
Post 20:02 ET
568.51MMarket Cap-6976P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.34%25.45M
65.34%102.56M
42.96%24.06M
91.90%33.18M
50.23%21.16M
74.73%24.16M
21.96%62.03M
13.11%16.83M
45.70%17.29M
30.19%14.08M
Selling and administrative expenses
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
14.65%22.41M
13.92%6.17M
8.82%5.13M
11.63%5.42M
-General and administrative expense
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
14.65%22.41M
13.92%6.17M
8.82%5.13M
11.63%5.42M
Research and development costs
8.98%18.59M
60.28%63.5M
63.81%17.46M
21.96%14.83M
63.37%14.15M
109.64%17.06M
26.53%39.62M
12.64%10.66M
70.01%12.16M
45.31%8.66M
Operating profit
-5.34%-25.45M
-65.34%-102.56M
-42.96%-24.06M
-91.90%-33.18M
-50.23%-21.16M
-74.73%-24.16M
-24.41%-62.03M
-21.26%-16.83M
-45.70%-17.29M
-30.19%-14.08M
Net non-operating interest income expense
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
1,141.18%2.11M
2,314.55%1.33M
918.37%499K
289.09%214K
Non-operating interest income
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
1,141.18%2.11M
2,314.55%1.33M
918.37%499K
289.09%214K
Other net income (expense)
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
-270.00%-68K
-140.00%-4K
-450.00%-14K
-238.46%-54K
Other non- operating income (expenses)
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
-270.00%-68K
-140.00%-4K
-450.00%-14K
-238.46%-54K
Income before tax
-3.76%-22.28M
-49.98%-89.97M
-35.26%-20.97M
-76.77%-29.71M
-28.01%-17.82M
-56.11%-21.47M
-20.82%-59.99M
-12.24%-15.5M
-42.25%-16.81M
-29.84%-13.92M
Income tax
61.67%97K
-33.24%239K
-84.59%49K
346.15%58K
1,100.00%72K
185.71%60K
-29.53%358K
-26.90%318K
-35.00%13K
-57.14%6K
Net income
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
-42.12%-16.82M
-29.73%-13.93M
Net income continuous Operations
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
-42.12%-16.82M
-29.73%-13.93M
Minority interest income
Net income attributable to the parent company
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
-42.12%-16.82M
-29.73%-13.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
-42.12%-16.82M
-29.73%-13.93M
Basic earnings per share
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
24.43%-1.67
48.21%-0.29
6.38%-0.44
-27.91%-0.55
Diluted earnings per share
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
24.43%-1.67
48.21%-0.29
6.38%-0.44
-27.91%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.34%25.45M65.34%102.56M42.96%24.06M91.90%33.18M50.23%21.16M74.73%24.16M21.96%62.03M13.11%16.83M45.70%17.29M30.19%14.08M
Selling and administrative expenses -3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M14.65%22.41M13.92%6.17M8.82%5.13M11.63%5.42M
-General and administrative expense -3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M14.65%22.41M13.92%6.17M8.82%5.13M11.63%5.42M
Research and development costs 8.98%18.59M60.28%63.5M63.81%17.46M21.96%14.83M63.37%14.15M109.64%17.06M26.53%39.62M12.64%10.66M70.01%12.16M45.31%8.66M
Operating profit -5.34%-25.45M-65.34%-102.56M-42.96%-24.06M-91.90%-33.18M-50.23%-21.16M-74.73%-24.16M-24.41%-62.03M-21.26%-16.83M-45.70%-17.29M-30.19%-14.08M
Net non-operating interest income expense 18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M1,141.18%2.11M2,314.55%1.33M918.37%499K289.09%214K
Non-operating interest income 18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M1,141.18%2.11M2,314.55%1.33M918.37%499K289.09%214K
Other net income (expense) -200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K-270.00%-68K-140.00%-4K-450.00%-14K-238.46%-54K
Other non- operating income (expenses) -200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K-270.00%-68K-140.00%-4K-450.00%-14K-238.46%-54K
Income before tax -3.76%-22.28M-49.98%-89.97M-35.26%-20.97M-76.77%-29.71M-28.01%-17.82M-56.11%-21.47M-20.82%-59.99M-12.24%-15.5M-42.25%-16.81M-29.84%-13.92M
Income tax 61.67%97K-33.24%239K-84.59%49K346.15%58K1,100.00%72K185.71%60K-29.53%358K-26.90%318K-35.00%13K-57.14%6K
Net income -3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M-42.12%-16.82M-29.73%-13.93M
Net income continuous Operations -3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M-42.12%-16.82M-29.73%-13.93M
Minority interest income
Net income attributable to the parent company -3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M-42.12%-16.82M-29.73%-13.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M-42.12%-16.82M-29.73%-13.93M
Basic earnings per share 3.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.3124.43%-1.6748.21%-0.296.38%-0.44-27.91%-0.55
Diluted earnings per share 3.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.3124.43%-1.6748.21%-0.296.38%-0.44-27.91%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg